Fullerene Derivative |
A23187 + FD* |
48/80 + FD* |
somatostatin +FD* |
poly-L-lysine + FD* |
| Biotin |
no Inh |
no Inh |
44.6 (±1.8)¥¥¥ |
no Inh |
| C70-OH |
19.0 (±1.1)¥¥¥ |
42.0 (±4.6)¥¥¥ |
13.4 (±5.2)¥ |
33.4 (±5.5)¥¥¥ |
| CCC |
no Inh |
no Inh |
23.8 (±0.8)¥¥¥ |
no Inh |
| DMAE |
18.6 (±7.9)¥ |
16.9 (±10.)¥¥¥ |
24.3 (±9.7)¥ |
no Inh |
| Ethanolamine |
36.0 (±3.0)¥¥¥ |
no Inh |
no Inh |
no Inh |
| Niacin |
no Inh |
59.5 (±1.3)¥¥¥ |
21.9 (±13.8)¥ |
20.9 (±12.6)¥ |
| NSAID |
21.1 (±11.4)¥ |
no Inh |
no Inh |
no Inh |
| PC4 |
no Inh |
no Inh |
21.6 (±2.9)¥¥¥ |
no Inh |
| Tetraglutamate |
22.3 (±3.9)¥¥¥ |
no Inh |
20.3 (±4.5)¥¥ |
17.9 (±13.1)¥ |
| Tetrainositol |
no Inh |
no Inh |
32.8 (±1.9)¥¥¥ |
no Inh |
| Tetraphosphate |
18.9 (±0.4)¥¥¥ |
no Inh |
no Inh |
no Inh |
| Tetrapyridine |
14.0 (±1.9)¥¥ |
34.8 (±8.1)¥¥ |
no Inh |
13.1 (±4.0)¥ |
| Tetrasulfonate |
21.1 (±6.3)¥ |
44.8 (±11.2)¥¥ |
22.0 (±5.50)¥¥ |
26.7 (±2.3)¥¥ |
| TGA |
49.8 (±8.9)¥¥¥ |
no Inh |
16.7 (±3.8)¥¥¥ |
43.8 (±10.6)¥¥ |
| TTA |
no Inh |
no Inh |
34.6 (±2.6)¥¥¥ |
52.4 (±4.3)¥¥¥ |
* FD Treatment at 10 μg/mL. ¥¥¥ p value < 0.01 / ¥¥ p value < 0.02 / ¥ p value < 0.05
/ no Inh = no significant inhibition observed |
